Opus Genetics (IRD) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 43.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.44% |
| Dec 31, 2025 | 48.71% |
| Sep 30, 2025 | -15.85% |
| Jun 30, 2025 | -21.69% |
| Mar 31, 2025 | -11.37% |
| Dec 31, 2024 | -39.96% |
| Sep 30, 2024 | -13.68% |
| Jun 30, 2024 | 3.52% |
| Mar 31, 2024 | 20.96% |
| Dec 31, 2023 | 18.45% |
| Sep 30, 2023 | 206.03% |
| Jun 30, 2023 | 134.95% |
| Mar 31, 2023 | 102.58% |
| Dec 31, 2022 | 73.78% |
| Sep 30, 2022 | -37.73% |
| Jun 30, 2022 | -29.75% |
| Mar 31, 2022 | 81.62% |
| Dec 31, 2021 | 49.61% |
| Sep 30, 2021 | 175.39% |
| Jun 30, 2021 | 163.16% |
| Mar 31, 2021 | -3.65% |
| Dec 31, 2020 | 966.95% |
| Sep 30, 2020 | 1.86% |
| Jun 30, 2020 | 25.98% |
| Mar 31, 2020 | 79.63% |
| Dec 31, 2019 | -82.42% |
| Sep 30, 2019 | 72.75% |
| Jun 30, 2019 | 43.50% |
| Mar 31, 2019 | -2.79% |
| Dec 31, 2018 | -1.74% |
| Sep 30, 2018 | -44.18% |
| Jun 30, 2018 | -42.05% |
| Mar 31, 2018 | -39.94% |
| Dec 31, 2017 | -23.14% |
| Sep 30, 2017 | -1.98% |
| Jun 30, 2017 | 11.58% |
| Mar 31, 2017 | 0.22% |
| Dec 31, 2016 | 13.52% |
| Sep 30, 2016 | -32.59% |
| Jun 30, 2016 | -20.99% |
| Mar 31, 2016 | -2.48% |
| Dec 31, 2015 | 3.80% |
| Sep 30, 2015 | -16.84% |
| Jun 30, 2015 | -73.83% |
| Mar 31, 2015 | -73.23% |
| Dec 31, 2014 | -47.42% |
| Sep 30, 2014 | 0.68% |
| Jun 30, 2014 | 281.83% |
| Mar 31, 2014 | 232.03% |
| Dec 31, 2013 | 38.57% |
| Sep 30, 2013 | 101.50% |
| Jun 30, 2013 | 17.64% |
| Mar 31, 2013 | 48.98% |
| Dec 31, 2012 | 36.76% |
| Sep 30, 2012 | -44.16% |
| Jun 30, 2012 | -47.40% |
| Mar 31, 2012 | -60.51% |
| Dec 31, 2011 | -20.09% |
| Sep 30, 2011 | -16.51% |
| Jun 30, 2011 | -9.47% |